- Home
- ATAT vs HTGC Comparison
ATAT vs HTGC Comparison
Compare ATAT & HTGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATAT
- HTGC
- Stock Information
- Founded
- ATAT 2013
- HTGC 2003
- Country
- ATAT China
- HTGC United States
- Employees
- ATAT N/A
- HTGC N/A
- Industry
- ATAT Hotels/Resorts
- HTGC Investment Managers
- Sector
- ATAT Consumer Discretionary
- HTGC Finance
- Exchange
- ATAT Nasdaq
- HTGC Nasdaq
- Market Cap
- ATAT 3.7B
- HTGC 3.3B
- IPO Year
- ATAT 2022
- HTGC 2005
- Fundamental
- Price
- ATAT $25.85
- HTGC $20.74
- Analyst Decision
- ATAT Strong Buy
- HTGC Buy
- Analyst Count
- ATAT 2
- HTGC 9
- Target Price
- ATAT $23.69
- HTGC $20.50
- AVG Volume (30 Days)
- ATAT 900.1K
- HTGC 977.3K
- Earning Date
- ATAT 11-19-2024
- HTGC 02-13-2025
- Dividend Yield
- ATAT 1.74%
- HTGC 7.71%
- EPS Growth
- ATAT 162.91
- HTGC 1.34
- EPS
- ATAT 1.20
- HTGC 2.01
- Revenue
- ATAT $950,764,843.00
- HTGC $494,410,000.00
- Revenue This Year
- ATAT $55.87
- HTGC $10.55
- Revenue Next Year
- ATAT $25.40
- HTGC $5.06
- P/E Ratio
- ATAT $21.59
- HTGC $10.32
- Revenue Growth
- ATAT 76.11
- HTGC 12.81
- 52 Week Low
- ATAT $15.22
- HTGC $16.72
- 52 Week High
- ATAT $29.90
- HTGC $21.78
- Technical
- Relative Strength Index (RSI)
- ATAT 46.80
- HTGC 67.77
- Support Level
- ATAT $24.92
- HTGC $19.48
- Resistance Level
- ATAT $26.04
- HTGC $20.65
- Average True Range (ATR)
- ATAT 0.94
- HTGC 0.35
- MACD
- ATAT -0.14
- HTGC 0.06
- Stochastic Oscillator
- ATAT 26.56
- HTGC 88.38
About ATAT Atour Lifestyle Holdings Limited
Atour Lifestyle Holdings Ltd is an upper-midscale hotel chain in China. The company derives revenues from franchise and management fees from its manachised hotels and sales of hotel supplies to manachised hotels, Operations of leased hotels, and sales of retail products. The company has one operating segment, which is the Atour Group.
About HTGC Hercules Capital Inc.
Hercules Capital Inc is a specialty finance company engaged in providing senior secured loans to high-growth, venture capital-backed companies in a variety of technology, life sciences, and sustainable and renewable technology industries. It invests majorly in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The company lends to and invests in portfolio companies in various technology-related industries including technology, drug discovery and development, biotechnology, life sciences, healthcare, and sustainable and renewable technology.